Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Simon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Australian and New Zealand Journal of Psychiatry|February 28, 2019
Electroconvulsive therapy in a patient with hypertrophic obstructive cardiomyopathyEmma Bowes, Anne Pf Wand, Sandy Simon
American Journal of Speech-Language Pathology|June 5, 2023
A Verbal Card Sorting Task to Measure Executive FunctionsArianna N LaCroix, Alexandria Greene-Winek, Sandy Simon, et al.
The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2022
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysisSandy Simon, Katherine E Francis, Janene E Dalrymple, et al.
Gynecologic Oncology|November 13, 2024
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancerKatherine Elizabeth Francis, Sandy Simon, Val Gebski, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Nature Communications|November 5, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trialChee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Australian and New Zealand Journal of Psychiatry|February 28, 2019
Electroconvulsive therapy in a patient with hypertrophic obstructive cardiomyopathyEmma Bowes, Anne Pf Wand, Sandy Simon
American Journal of Speech-Language Pathology|June 5, 2023
A Verbal Card Sorting Task to Measure Executive FunctionsArianna N LaCroix, Alexandria Greene-Winek, Sandy Simon, et al.
The Oncologist|July 24, 2025
Under the radar-frequency, timing, duration and trajectory of lower grade adverse events in clinical trials of anti-cancer therapiesKatherine E Francis, Sarah J Lord, Sandy Simon, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2022
Adverse events in the placebo arm of maintenance therapy trials in advanced ovarian cancer: A systematic review and meta-analysisSandy Simon, Katherine E Francis, Janene E Dalrymple, et al.
Gynecologic Oncology|November 13, 2024
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancerKatherine Elizabeth Francis, Sandy Simon, Val Gebski, et al.
Cell Reports|April 14, 2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPGAnahid Ehteda, Sandy Simon, Laura Franshaw, et al.
Nature Communications|November 5, 2025
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trialChee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, et al.
Pageof 1